Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)Recruiting
NCT07496567Phase 2, Phase 3Updated Aug 6, 2026
Sponsor: EyeBiotech Ltd.
Macular Degeneration · Age-Related Macular Degeneration · Choroidal Neovascularization · Wet Macular Degeneration
United States, Brazil, Colombia, Czechia, France +4 more
Rollover Study for Participants Previously Enrolled in Clinical Trials of PovorcitinibRecruiting
NCT06855498Phase 3Updated Aug 6, 2026
Sponsor: Incyte Corporation
Hidradenitis Suppurativa (HS)
United States, Argentina, Australia, Austria, Belgium +15 more
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder CancerRecruiting
NCT06510374Phase 3Updated Aug 6, 2026
Sponsor: Ferring Pharmaceuticals
Intermediate Risk Non-Muscle Invasive Bladder Cancer
United States, Canada, Czechia, Denmark, France +4 more
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)Recruiting
NCT07391657Phase 3Updated Aug 6, 2026
Sponsor: AstraZeneca
Relapsed Refractory Multiple Myeloma
United States, Australia, Brazil, Canada, China +10 more
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsRecruiting
NCT05232916Phase 3Updated Aug 6, 2026
Sponsor: Greenwich LifeSciences, Inc.
Breast Cancer
United States, Belgium, France, Germany, Ireland +5 more
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic ArthritisRecruiting
NCT04804553Phase 3Updated Aug 6, 2026
Sponsor: Amgen
Active Juvenile Psoriatic Arthritis
Austria, Belgium, France, Germany, Greece +10 more
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)Recruiting
NCT07241390Phase 3Updated Aug 6, 2026
Sponsor: Eli Lilly and Company
Atherosclerosis Cardiovascular Disease · Chronic Kidney Disease
Argentina, Australia, Austria, Belgium, Brazil +33 more
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRecruiting
NCT07169578Phase 3Updated Aug 6, 2026
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Brazil, Canada, China +8 more
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia ARecruiting
NCT07416604Phase 3Updated Aug 6, 2026
Sponsor: Hoffmann-La Roche
Hemophilia A
United States, Belgium, China, France, Germany +10 more
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal CancerRecruiting
NCT07284849Phase 3Updated Aug 6, 2026
Sponsor: Incyte Corporation
CRC (Colorectal Cancer)
United States, Argentina, Australia, Austria, Belgium +16 more
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential ThrombocythemiaRecruiting
NCT07623200Phase 3Updated Aug 6, 2026
Sponsor: Incyte Corporation
Essential Thrombocythemia
United States, Australia, Austria, Belgium, Canada +13 more
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisRecruiting
NCT06461897Phase 3Updated Aug 6, 2026
Sponsor: AbbVie
Atopic Dermatitis
United States, Argentina, Australia, Austria, Brazil +21 more
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress SyndromeRecruiting
NCT06776783Phase 3Updated Aug 6, 2026
Sponsor: Aerogen Pharma Limited
Respiratory Distress Syndrome · Pre-term Infants
United States
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2Recruiting
NCT04628026Phase 3Updated Aug 6, 2026
Sponsor: University of Ulm
Acute Myeloid Leukemia
Austria, Belgium, Estonia, Finland, Germany +3 more
Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)Recruiting
NCT07317934Phase 3Updated Aug 6, 2026
Sponsor: Innostellar Biotherapeutics Co.,Ltd
Neovascular Age-Related Macular Degeneration (nAMD) · Wet AMD
China
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)Recruiting
NCT07440225Phase 2, Phase 3Updated Aug 6, 2026
Sponsor: EyeBiotech Ltd.
Macular Degeneration · Age-Related Macular Degeneration · Choroidal Neovascularization · Wet Macular Degeneration
United States, Argentina, Australia, Israel, Latvia +3 more
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionRecruiting
NCT07214779Phase 3Updated Aug 6, 2026
Sponsor: Incyte Corporation
Ovarian Cancer
United States, Australia, Belgium, Canada, France +11 more
A Study of Brenipatide in Adult Participants With Major Depressive DisorderRecruiting
NCT07412756Phase 3Updated Aug 6, 2026
Sponsor: Eli Lilly and Company
Depressive Disorder, Major
United States, Australia, Brazil, Canada, China +10 more
Study of COYA 302 for the Treatment of ALSRecruiting
NCT07161999Phase 2, Phase 3Updated Aug 6, 2026
Sponsor: Coya Therapeutics
Amyotrophic Lateral Sclerosis (ALS)
United States, Canada
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)Recruiting
NCT06881784Phase 3Updated Aug 6, 2026
Sponsor: Revolution Medicines, Inc.
NSCLC (Non-small Cell Lung Cancer) · Non-Small Cell Lung Cancer · NSCLC · NSCLC (Non-small Cell Lung Carcinoma)
United States, Australia, Belgium, France, Germany +14 more
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or OverweightRecruiting
NCT07369011Phase 3Updated Aug 6, 2026
Sponsor: Eli Lilly and Company
Sleep Apnea, Obstructive · Obesity · Overweight
United States, Australia, Brazil, Canada, China +6 more
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid CancerRecruiting
NCT06475989Phase 3Updated Aug 6, 2026
Sponsor: ECOG-ACRIN Cancer Research Group
Refractory Differentiated Thyroid Gland Carcinoma
United States
Lumateperone for Late-Life DepressionRecruiting
NCT07623135Phase 3Updated Aug 6, 2026
Sponsor: Eric Lenze
Treatment Resistant Depression (TRD) · Late Life Depression (LLD) · Depression / Major Depressive Disorder
United States
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or OverweightRecruiting
NCT07202884Phase 3Updated Aug 6, 2026
Sponsor: Eli Lilly and Company
Urinary Incontinence,Stress
United States, Canada, China, Czechia, India +5 more
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRecruiting
NCT07170150Phase 3Updated Aug 6, 2026
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Australia, Brazil, Canada +11 more

Previous page Next page